NRXP NRX Pharmaceuticals, Inc. Common Stock

XNAS 2.82 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

NRXP $2.82 —
Key stats
$2.82
52-Week Range
$1.62 – $5.05
YTD
+7.63%
IV Rank (30D)
31.77
Straddle Price
$1.35
P/C Vol Ratio
0.16
Market Cap
$0.1B
Fair Value
-50.0% vs price

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)5.29%
Beta vs SPY1.05
Cost of Equity (CAPM)11.08% (VRP-adj)
WACC10.93%
Volatility Risk Premium+233.3pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.0B
Return on Equity (TTM)13811.8%
Book / Price-20.3%
Gross Margin (TTM)50.5%
FCF Margin (TTM)-901.5%
Quality Score2/6 — normal (10y DCF)
SMA 50$3.33 (Market Anchor value)
SMA 20 / Bollinger Mid$3.22
Bollinger Width / SMA20876.0% (drives anchor stability)
Net Debt$-0.0B
Market Cap$0B
Peers used for multiples: ABBV, ANRO, CMPS, DFTX, JNJ, NBIX, RLMD, SUPN
Blended Fair Value
$0.53
Deviation
-50.0%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 29.6× · 3 peers
Peer EV/EBITDA n/a 0% median 18.5× · 4 peers
Peer P/B n/a 0% median 4.5× · 7 peers
Peer P/S $0.53 100% median 5.3× · 4 peers
Market Anchor (SMA50) $3.33 0% stability 0% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-10-05 · updated
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNAS
Market Cap
$0.1B

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
MonthAvg ReturnYears of Data
Jan -6.97% 5
Feb -10.50% 5
Mar -3.94% 5
Apr -10.20% 5
May +19.15% 6
Jun -17.96% 6
Jul +0.73% 6
Aug -12.79% 6
Sep -4.29% 6
Oct +1.20% 6
Nov +6.53% 5
Dec +10.64% 5
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $3.18
SMA 50: $3.31
SMA 200: $2.94
Current: $2.82
EMA 12: $3.01
EMA 26: $3.18
MACD: -0.1643 | Signal: -0.0352
BEARISH
ADX (14): 19.43
RANGE
+DI: 13.53
−DI: 25.88

Momentum Oscillators

RSI (14): 31.07
NEUTRAL
Stoch %K: 6.36
Stoch %D: 6.22
Williams %R: -95.24

Volume & Volatility

BB Upper: $3.65
BB Lower: $2.72
NEUTRAL
OBV: 54,529,310
Vol SMA 20: 697,811
Vol ROC: 8.63%
ATR: $0.17
True Range: $0.15
HV 20: 35.1%
HV 30: 43.1%
HV 60: 63.9%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-04T00:00:00 – 2026-10-02T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary Overall Assessment: BEARISH (Confidence Level: 7/10) Key Drivers: High volatility, negative recent news sentiment, technical breakdown Primary Risks: High risk due to beta >1.5 and high volatility Investment Thesis: NRXP's stock price is expected to decline in the short-term due to negative recent news sentiment and technical signals.

Recent News Sentiment Impact: The recent news headlines have been mixed, but the overall sentiment has been slightly negative. This has contributed to the bearish assessment.

Technical Analysis Trend Direction:

  • Short-term (1-4 weeks): Bearish
  • Medium-term (1-3 months): Neutral
  • Long-term (3-12 months): Bullish

Support/Resistance Levels: Key levels include $2.73 (lower Bollinger Band), $3.43 (current price), and $4.13 (upper Bollinger Band).

Momentum Signals:

  • RSI interpretation: Overbought (>70) at 46.83, indicating a potential sell signal.
  • MACD signal: Bearish due to the MACD histogram being below the zero line.
  • Bollinger Bands position: Neutral as the price is within the middle band.

Volume Analysis: Volume has been declining recently, which may indicate institutional disinterest and further selling pressure.

News & Sentiment Analysis Recent Headlines Summary: The news headlines have been mixed, but the overall sentiment has been slightly negative. The article about NRXP's public offering of common stock was neutral, while the articles discussing the company's financial results and appointments were positive. However, the recent decline in stock price due to earnings misses has contributed to a bearish sentiment.

Sentiment Assessment: Slightly Negative

Catalyst Identification: Upcoming earnings reports and product launches may impact the stock price.

Market Narrative: The technical signals are currently more bearish than the news sentiment, which may indicate a potential short-term decline in the stock price.

Risk & Volatility Assessment Beta Interpretation: High risk relative to the market (beta >1.5).

Volatility Regime: Current volatility is high compared to historical levels.

Options Market Signals:

  • IV rank: 41.0% (Medium)
  • Put/call ratios: Bearish sentiment
  • Unusual activity: High call volume and open interest

Downside Protection: Support levels include $2.73 (lower Bollinger Band) and $3.43 (current price).

Market Context & Positioning Sector Performance: Biotech sector has been strong recently, which may indicate that NRXP's stock price is due for a rebound.

Institutional Activity: Volume patterns suggest institutional disinterest and further selling pressure.

Correlation Analysis: The stock moves relatively strongly with the market (R-squared = 0.30).

Relative Valuation: The stock is trading within its normal range, but the recent decline may indicate that it's undervalued.

Key Levels & Action Items Critical Price Levels:

  • Support: $2.73 (lower Bollinger Band), $3.43 (current price)
  • Resistance: $4.13 (upper Bollinger Band)

Breakout/Breakdown Levels:

  • Breakout level: $4.13 (upper Bollinger Band)
  • Breakdown level: $2.73 (lower Bollinger Band)

Time-Sensitive Catalysts:

  • Upcoming earnings reports and product launches

Risk Management:

  • Stop-loss levels: Consider placing a stop-loss order around the support level ($2.73 or $3.43)
  • Position sizing considerations: Reduce position size due to high risk and volatility.

By analyzing the data, I have concluded that NRXP's stock price is expected to decline in the short-term due to negative recent news sentiment and technical signals. The company's high beta and volatility also contribute to its high risk profile. However, the biotech sector has been strong recently, which may indicate that NRXP's stock price is due for a rebound.

Generated
News
Earnings History
5 of 5 under expected move
Avg Expected Move
67.79%
Avg Actual Move
2.77%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-11-15 Pre-Market 207.63% 1.69% 0.01x Within
2025-03-21 After-Close 18.87% 3.77% 0.20x Within
2025-05-21 After-Close 40.68% 2.28% 0.06x Within
2025-08-18 After-Close 31.70% 5.80% 0.18x Within
2026-08-17 After-Close 40.09% 0.29% 0.01x Within

NRXP Options Activity & IV Rank

NRXP IV rank history, 52-week IV rank and IV percentile →

IV Rank (30D)
31.77
IV Rank (7D)
10.44
IV (30D ATM)
143.1%
Straddle (30D)
$1.35
Straddle (7D)
$1.02
P/C Volume
0.16
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
2.05
Correlation (SPY)
30.9%
R²
0.10
Ann. Volatility
86.4%
SPY Volatility
13.0%

High volatility - stock moves more than market

Beta & Alpha Over Time

NRXP Institutional Ownership (13F)

Latest filings — 2026-06-30
Diluted shares outstanding: 23,473,095 (as of 2026-03-31)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

48 filers12,368,728 shares$49.56M value52.69% of float
# Filer Shares Value % of Total % of Float Period
1 B Group, Inc. 4,091,767 $16.74M 33.77% 17.43% 2026-06-30
2 Vanguard Capital Management LLC 1,618,159 $6.62M 13.35% 6.89% 2026-06-30
3 Ameriprise Financial, Inc. Custodian 928,728 $3.80M 7.66% 3.96% 2026-06-30
4 Balyasny Asset Management L.P. 893,864 $3.66M 7.38% 3.81% 2026-06-30
5 Citadel Advisors LLC Custodian 680,043 $2.78M 5.61% 2.90% 2026-06-30
6 AdvisorShares Investments LLC 659,018 $2.70M 5.44% 2.81% 2026-06-30
7 Vanguard Group Inc Custodian 729,842 $1.98M 3.99% 3.11% 2025-12-31
8 COMMONWEALTH EQUITY SERVICES, LLC 454,418 $1.86M 3.75% 1.94% 2026-06-30
9 UBS Group AG Custodian 423,115 $1.73M 3.49% 1.80% 2026-06-30
10 Geode Capital Management, LLC Custodian 314,659 $1.29M 2.60% 1.34% 2026-06-30
11 BlackRock, Inc. Custodian 220,460 $901.68K 1.82% 0.94% 2026-06-30
12 Marshall Wace, LLP Custodian 194,580 $795.83K 1.61% 0.83% 2026-06-30
13 Vanguard Fiduciary Trust Co 182,718 $747.32K 1.51% 0.78% 2026-06-30
14 Jane Street Group, LLC Custodian 119,018 $486.78K 0.98% 0.51% 2026-06-30
15 Bleakley Financial Group, LLC 117,216 $479.41K 0.97% 0.50% 2026-06-30
16 State Street Corp 116,084 $474.78K 0.96% 0.49% 2026-06-30
17 HRT FINANCIAL LP 100,724 $411.00K 0.83% 0.43% 2026-06-30
18 Northern Trust Corp Custodian 62,951 $257.47K 0.52% 0.27% 2026-06-30
19 Chicago Partners Investment Group LLC 46,388 $190.66K 0.38% 0.20% 2026-06-30
20 Quadrature Capital Ltd 43,605 $178.34K 0.36% 0.19% 2026-06-30
21 One Wealth Management Investment & Advisory Services, LLC 43,309 $177.13K 0.36% 0.18% 2026-06-30
22 Morgan Stanley Custodian 40,901 $167.28K 0.34% 0.17% 2026-06-30
23 RENAISSANCE TECHNOLOGIES LLC 38,600 $157.87K 0.32% 0.16% 2026-06-30
24 Global Retirement Partners, LLC 33,300 $136.20K 0.27% 0.14% 2026-06-30
25 Two Sigma Investments, LP Custodian 26,429 $108.09K 0.22% 0.11% 2026-06-30
3 filers$1.92M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $927.61K 48.30% 2026-06-30
2 Citadel Advisors LLC Custodian $916.98K 47.74% 2026-06-30
3 Jane Street Group, LLC Custodian $76.07K 3.96% 2026-06-30
2 filers$324.75K notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $215.54K 66.37% 2026-06-30
2 Citadel Advisors LLC Custodian $109.20K 33.63% 2026-06-30
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

P/B Ratio-725.8
P/S Ratio36.4
EV/EBITDA-4.9
TTM Revenue$0.0B
TTM Net Income$-0.0B
TTM EPS$-1.09
ROE13811.8%
Debt/Equity-2.42